Stock ZENI.P ZENITH CAPITAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Zenith Capital Corporation

Equities

ZENI.P

CA98936P1071

Delayed Toronto S.E.
Other stock markets
 08:30:00 16/04/2024 pm IST 		5-day change 1st Jan Change
0.105 CAD -.--% Intraday chart for Zenith Capital Corporation -.--% -.--%
28/03 Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
2023 Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023
CI
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
CI
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
CI
Grand Samsara Consulting LLC and CBGB Ventures Corp. signed a binding letter agreement to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.
CI
IIROC Trading Halt - ZENI.P
AQ
Zenith Capital Corporation announced that it expects to receive CAD 1 million in funding from Grand Samsara Consulting LLC
CI
Zenith Capital Corporation announced that it has received CAD 0.2 million in funding
CI
Zenith Capital Corporation announced that it expects to receive CAD 0.2 million in funding
CI
IIROC Trading Resumption - ZENI.P
AQ
Venda Robotix Ltd cancelled the acquisition of Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction..
CI
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022
CI
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2022
CI
IIROC Trading Halt - ZENI.P
AQ
Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
AQ
ZENITH CAPITAL CORPORATION PROVIDES UPDATE TO PREVIOUSLY ANNOUNCED QUALIFYING TRANSACTION WITH VENDA ROBOTIX
AQ
Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the American Society of Clinical Oncology Conference (ASCO)
AQ
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022
CI
Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer Clinical Trial
AQ
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZENI.P Stock
  4. News Zenith Capital Corporation